Literature DB >> 6941314

Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.

S J List, P Seeman.   

Abstract

A procedure was developed to identify receptors for dopamine and serotonin separately and selectively by means of [3H]spiperone and to measure the density of each receptor in different regions of the rat brain. In the striatum, the binding of [3H]spiperone to dopamine receptors was inhibited by sulpiride but not by quinazolinedone R43448 (R43448); in the frontal cortex, however, the binding of [3H]spiperone to serotonin receptors was inhibited by R43448 but not by sulpiride. Thus, the density of dopamine receptors (D2 sites) was measured by [3H]spiperone binding in the presence of 0.1 microM R43448 (to preclude the attachment of the 3H-labeled ligand to serotonin sites), while the density of serotonin receptors (S2 sites) was measured by [3H]spiperone binding in the presence of 10 microM sulpiride (to preclude the attachment of the 3H-labeled ligand to dopamine sites). The density of D2 sites was highest in the striatum, followed by the olfactory tubercle, hypothalamus, substantia nigra, and the lower pons--medulla region. All five regions had similar dissociation constants (Kd values) of 0.05--0.15 nM. The density of S2 sites was highest in the frontal cortex, followed by the posterior cortex, olfactory tubercle, striatum, hypothalamus, and thalamus, and all regions had Kd values in the range 0.6--2.3 nM. Thus, because the Kd values were similar for all regions, and because Scatchard analyses revealed a single set of sites for either D2 or S2 (where detected), the main criteria for resolving the dopamine and serotonin components of [3H]spiperone binding were considered fulfilled.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941314      PMCID: PMC319401          DOI: 10.1073/pnas.78.4.2620

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

Authors:  S J Peroutka; D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Neuropharmacology       Date:  1977-09       Impact factor: 5.250

2.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.

Authors:  J E Leysen; W Gommeren; P M Laduron
Journal:  Biochem Pharmacol       Date:  1978-02-01       Impact factor: 5.858

3.  Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol.

Authors:  J Z Fields; T D Reisine; H I Yamamura
Journal:  Brain Res       Date:  1977-11-18       Impact factor: 3.252

4.  Serotonergic component of neuroleptic receptors.

Authors:  J E Leysen; C J Niemegeers; J P Tollenaere; P M Laduron
Journal:  Nature       Date:  1978-03-09       Impact factor: 49.962

5.  Use of ADTN to define specific 3H-spirerone binding to receptors in brain.

Authors:  M Quik; L L Iversen; A Larder; A V Mackay
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

6.  3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus.

Authors:  I Creese; S H Snyder
Journal:  Eur J Pharmacol       Date:  1978-05-15       Impact factor: 4.432

7.  Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.

Authors:  P M Whitaker; P Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

8.  Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.

Authors:  P Seeman; M Chau-Wong; J Tedesco; K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

9.  Serotonin receptors in hippocampus and frontal cortex.

Authors:  P Seeman; K Westman; D Coscina; J J Warsh
Journal:  Eur J Pharmacol       Date:  1980-08-29       Impact factor: 4.432

10.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

Authors:  P Seeman; M Chau-Wong; J Tedesco; K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

View more
  23 in total

1.  Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.

Authors:  Chantevy Pou; Clotilde Mannoury la Cour; Leigh A Stoddart; Mark J Millan; Graeme Milligan
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

2.  Functional reconstitution of rat striatal dopamine agonist receptors into artificial lipid bimolecular membranes.

Authors:  R B Murphy; V Vodyanoy
Journal:  Biophys J       Date:  1984-01       Impact factor: 4.033

Review 3.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

Review 4.  Antidepressants and serotonergic neurotransmission: an integrative review.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: II. Dopamine receptors.

Authors:  D K Lim; Z J Yu; B Hoskins; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

6.  PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.

Authors:  H H Coenen; K Wienhard; G Stöcklin; P Laufer; I Hebold; G Pawlik; W D Heiss
Journal:  Eur J Nucl Med       Date:  1988

7.  Increased dopamine receptor binding in duodenal mucosa of duodenal ulcer patients.

Authors:  D E Hernandez; C H Walker; J E Valenzuela; G A Mason
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

8.  The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.

Authors:  K J Pittman; A Jakubovic; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

Authors:  H B Niznik; D E Grigoriadis; I Pri-Bar; O Buchman; P Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

10.  Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.

Authors:  S W Tam; L Cook
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.